Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States.
Bensimon, Arielle G; Zhou, Zheng-Yi; Jenkins, Madeline; Song, Yan; Gao, Wei; Signorovitch, James; Krepler, Clemens; Liu, Frank Xiaoqing; Wang, Jingshu; Aguiar-Ibáñez, Raquel.
J Med Econ
; : 1-13, 2019 Apr 23.
Artigo em Inglês | MEDLINE | ID: mdl-31012765
Cost-effectiveness of magnetic resonance imaging versus ultrasound for the detection of symptomatic full-thickness supraspinatus tendon tears.
Clinical Decision Analysis and Markov Modeling for Surgeons: An Introductory Overview.
Cost-effectiveness of early laparoscopic cholecystectomy for mild acute gallstone pancreatitis.
Cost Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal.
Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer.
Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
Negative pressure wound therapy for open traumatic wounds.
Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis.
The Cost-Effectiveness of Cognitive-Behavioral Group Training for Patients with Unexplained Physical Symptoms.
Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D.